Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
作者信息
Sloan Emily A, Hilz Stephanie, Gupta Rohit, Cadwell Cathryn, Ramani Biswarathan, Hofmann Jeffrey, Kline Cassie N, Banerjee Anu, Reddy Alyssa, Oberheim Bush Nancy Ann, Chang Susan, Braunstein Steve, Chang Edward F, Raffel Corey, Gupta Nalin, Sun Peter P, Kim John Y H, Moes Gregory, Alva Elizabeth, Li Rong, Bruggers Carol S, Alashari Mouied, Wetmore Cynthia, Garg Shipra, Dishop Megan, Van Ziffle Jessica, Onodera Courtney, Devine Patrick, Grenert James P, Lee Julieann C, Phillips Joanna J, Pekmezci Melike, Tihan Tarik, Bollen Andrew W, Berger Mitchel S, Costello Joseph F, Perry Arie, Solomon David A
机构信息
Department of Pathology, University of California, San Francisco, CA, USA.
Department of Neurological Surgery, University of California, San Francisco, CA, USA.
出版信息
Acta Neuropathol. 2020 May;139(5):953-957. doi: 10.1007/s00401-020-02144-8. Epub 2020 Mar 10.
Abstract
摘要
相似文献
1
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
Acta Neuropathol. 2020 May;139(5):953-957. doi: 10.1007/s00401-020-02144-8. Epub 2020 Mar 10.
2
Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
Hum Mutat. 2014 Jun;35(6):654-62. doi: 10.1002/humu.22559.
3
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome.
Acta Neuropathol Commun. 2023 Jan 6;11(1):3. doi: 10.1186/s40478-022-01490-w.
4
Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
Mol Carcinog. 2013 Oct;52(10):770-6. doi: 10.1002/mc.21912. Epub 2012 Apr 11.
5
Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li-Fraumeni syndrome.
Leukemia. 2021 May;35(5):1475-1479. doi: 10.1038/s41375-021-01163-y. Epub 2021 Feb 12.
6
p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome.
Pediatr Dev Pathol. 2010 May-Jun;13(3):218-24. doi: 10.2350/09-08-0694-OA.1.
7
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5.
8
Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.
J Pediatr Hematol Oncol. 2018 Apr;40(3):e195-e197. doi: 10.1097/MPH.0000000000000948.
9
A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family.
Cancer Genet Cytogenet. 1998 May;103(1):1-6. doi: 10.1016/s0165-4608(97)00258-6.
10
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Cancer Lett. 2007 Jan 8;245(1-2):96-102. doi: 10.1016/j.canlet.2005.12.039. Epub 2006 Feb 21.
引用本文的文献
1
National and subnational burden of brain and central nervous system cancers in China and global from 1990 to 2021: results from the global burden of disease study 2021.
Arch Public Health. 2025 Jul 28;83(1):195. doi: 10.1186/s13690-025-01683-4.
2
A systematic review of high-grade glioma associated with Li-Fraumeni syndrome.
Neurosurg Rev. 2025 Mar 10;48(1):290. doi: 10.1007/s10143-025-03437-w.
3
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.
Neurooncol Adv. 2025 Jan 29;7(1):vdaf024. doi: 10.1093/noajnl/vdaf024. eCollection 2025 Jan-Dec.
4
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome.
Acta Neuropathol Commun. 2025 Jan 16;13(1):8. doi: 10.1186/s40478-024-01885-x.
5
Dual PTCH2 mutation [Ser391*, Leu104Pro]: unveiling a potential new genetic susceptibility factor for glioma development.
Invest New Drugs. 2025 Feb;43(1):126-134. doi: 10.1007/s10637-024-01491-7. Epub 2025 Jan 13.
6
Current insights and future directions of Li-Fraumeni syndrome.
Discov Oncol. 2024 Oct 15;15(1):561. doi: 10.1007/s12672-024-01435-w.
7
Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches.
Int J Mol Sci. 2024 May 26;25(11):5774. doi: 10.3390/ijms25115774.
8
Glioma.
Nat Rev Dis Primers. 2024 May 9;10(1):33. doi: 10.1038/s41572-024-00516-y.
9
Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases.
Acta Neuropathol Commun. 2024 Apr 11;12(1):57. doi: 10.1186/s40478-024-01762-7.
10
Case report: Turcot syndrome type 2 in a developing country within the Caribbean.
Front Oncol. 2024 Mar 14;14:1331271. doi: 10.3389/fonc.2024.1331271. eCollection 2024.
本文引用的文献
1
An update on the central nervous system manifestations of Li-Fraumeni syndrome.
Acta Neuropathol. 2020 Apr;139(4):669-687. doi: 10.1007/s00401-019-02055-3. Epub 2019 Aug 30.
2
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10.
3
Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts.
Acta Neuropathol Commun. 2018 Sep 19;6(1):95. doi: 10.1186/s40478-018-0598-x.
4
The genetic landscape of gliomas arising after therapeutic radiation.
Acta Neuropathol. 2019 Jan;137(1):139-150. doi: 10.1007/s00401-018-1906-z. Epub 2018 Sep 8.
5
The genetic landscape of ganglioglioma.
Acta Neuropathol Commun. 2018 Jun 7;6(1):47. doi: 10.1186/s40478-018-0551-z.
6
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Lancet Oncol. 2018 Jun;19(6):785-798. doi: 10.1016/S1470-2045(18)30242-0. Epub 2018 May 9.
7
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.
Neuro Oncol. 2018 Apr 9;20(5):632-641. doi: 10.1093/neuonc/nox205.
8
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45. doi: 10.1158/1078-0432.CCR-17-0408.
9
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Neuro Oncol. 2017 May 1;19(5):699-709. doi: 10.1093/neuonc/now254.
10
IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
Acta Neuropathol. 2016 Jul;132(1):153-5. doi: 10.1007/s00401-016-1579-4. Epub 2016 May 9.
Zotero 插件